Variant ID: 8-6396870-G-C

NM_001118887.1(ANGPT2):c.289-6862C>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.

International Journal Of Molecular Sciences
Gaibar, María M; Galán, Miguel M; Romero-Lorca, Alicia A; Antón, Beatriz B; Malón, Diego D; Moreno, Amalia A; Fernández-Santander, Ana A; Novillo, Apolonia A
Publication Date: 2021-01-30

Variant appearance in text: rs1375668
PubMed Link: 33573134
Variant Present in the following documents:
  • Main text
  • ijms-22-01381.pdf
View BVdb publication page



Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
Makhoul, Issam I; Todorova, Valentina K VK; Siegel, Eric R ER; Erickson, Stephen W SW; Dhakal, Ishwori I; Raj, Vinay R VR; Lee, Jeannette Y JY; Orloff, Mohammed S MS; Griffin, Robert J RJ; Henry-Tillman, Ronda S RS; Klimberg, Suzanne S; Hutchins, Laura F LF; Kadlubar, Susan A SA
Publication Date: 2017

Variant appearance in text: rs1375668
PubMed Link: 28045923
Variant Present in the following documents:
  • Main text
View BVdb publication page



Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis.

Omics : A Journal Of Integrative Biology
Chalise, Prabhakar P; Batzler, Anthony A; Abo, Ryan R; Wang, Liewei L; Fridley, Brooke L BL
Publication Date: 2012

Variant appearance in text: rs1375668
PubMed Link: 22734853
Variant Present in the following documents:
  • Main text
View BVdb publication page